​

Mirum Pharmaceuticals (MIRM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Mirum Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$336.89M

Latest Revenue (Q)

$77.88M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Mirum Pharmaceuticals Revenue by Period

Mirum Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$336.89M80.76%
2023-12-31$186.37M141.85%
2022-12-31$77.06M302.66%
2021-12-31$19.14M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Mirum Pharmaceuticals generated $336.89M in revenue during NA 2024, up 80.76% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Mirum Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-06-30$77.88M12.50%
2024-03-31$69.22M-0.48%
2023-12-31$69.55M45.74%
2023-09-30$47.73M27.28%
2023-06-30$37.50M18.67%
2023-03-31$31.60M13.23%
2022-12-31$27.91M48.59%
2022-09-30$18.78M7.41%
2022-06-30$17.48M35.62%
2022-03-31$12.89M310.83%
2021-12-31$3.14M-37.24%
2021-09-30$5.00M-54.55%
2021-06-30$11.00M100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30--

Mirum Pharmaceuticals generated $77.88M in revenue during Q2 2024, up 12.50% compared to the previous quarter, and up 246.46% compared to the same period a year ago.

Mirum Pharmaceuticals Revenue Breakdown

Mirum Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21
License and Other Revenue$479.00K---
Product$336.41M$178.87M$75.06M$3.14M
License Revenue-$7.50M--
License--$2.00M$16.00M

Mirum Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (99.86%), and License and Other Revenue (0.14%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
License and Other Revenue$99.00K$75.00K$305.00K--------
Product$177.19M$90.30M$68.92M$69.55M$47.73M$32.50M$29.10M$27.91M$18.78M$17.48M$10.89M
License Revenue----$7.50M------
License-----$5.00M$2.50M---$2.00M

Mirum Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (99.94%), and License and Other Revenue (0.06%).

Mirum Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 23
UNITED STATES$274.17M$146.70M
Rest of the World$62.24M-
Rest of World-$32.17M

Mirum Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (81.50%), and Rest of the World (18.50%).

Quarterly Revenue by Country

CountryDec 24Sep 24Mar 24
UNITED STATES$144.16M$73.91M$56.11M
Rest Of World-$16.40M$12.81M

Mirum Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Dec 24: UNITED STATES (100.00%).

Mirum Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
APLSApellis Pharmaceuticals$709.95M$176.57M
BPMCBlueprint Medicines$508.82M$128.18M
MIRMMirum Pharmaceuticals$336.89M$77.88M
IMCRImmunocore$310.20M$75.40M
ARQTArcutis Biotherapeutics$196.54M$30.86M
DAWNDay One Biopharmaceuticals$131.16M$20.07M
AMLXAmylyx Pharmaceuticals$87.37M$416.00K
XFORX4 Pharmaceuticals$2.56M$560.00K
LYRALyra Therapeutics$1.53M$195.00K
KALVKalVista Pharmaceuticals--
MLTXMoonLake Immunotherapeutics--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
LRMRLarimar Therapeutics--

MIRM Revenue FAQ

What is Mirum Pharmaceuticals’s yearly revenue?

Mirum Pharmaceuticals's yearly revenue for 2024 was $336.89M, representing an increase of 80.76% compared to 2023. The company's yearly revenue for 2023 was $186.37M, representing an increase of 141.85% compared to 2022. MIRM's yearly revenue for 2022 was $77.06M, representing an increase of 302.66% compared to 2021.

What is Mirum Pharmaceuticals’s quarterly revenue?

Mirum Pharmaceuticals's quarterly revenue for Q2 2024 was $77.88M, a 12.50% increase from the previous quarter (Q1 2024), and a 107.68% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $69.22M, a -0.48% decrease from the previous quarter (Q4 2023), and a 119.07% increase year-over-year (Q1 2023). MIRM's quarterly revenue for Q4 2023 was $69.55M, a 45.74% increase from the previous quarter (Q3 2023), and a 149.24% increase year-over-year (Q4 2022).

What is Mirum Pharmaceuticals’s revenue growth rate?

Mirum Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 337.16%, and for the last 5 years (2020-2024) was 0%.

What are Mirum Pharmaceuticals’s revenue streams?

Mirum Pharmaceuticals's revenue streams in c 24 are License and Other Revenue, and Product. License and Other Revenue generated $479K in revenue, accounting 0.14% of the company's total revenue Product generated $336.41M in revenue, accounting 99.86% of the company's total revenue, up 88.07% year-over-year.

What is Mirum Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Mirum Pharmaceuticals was Product. This segment made a revenue of $336.41M, representing 99.86% of the company's total revenue.